日期 | 股东名称 | 披露原因 | 买入/卖出涉及 的股份数目 |
每股平均价 | 持有权益的 股份数目 |
占已发行 股本(%) |
30/05/2025 | UBS Group AG | 1305(L) | 12,660,880(L) | 465,355,527(L) 465,433,024(S) | 12.37 12.37 | |
28/05/2025 | UBS Group AG | 1305(L) | 130,638,742(L) | 468,190,302(L) 471,530,169(S) | 12.45 12.54 | |
27/05/2025 | UBS Group AG | 1402(S) | +24,838,597(S) | 472,535,967(L) 475,354,334(S) | 12.56 12.64 | |
26/05/2025 | UBS Group AG | 1502(S) | -3,781,369(S) | 463,519,141(L) 448,057,378(S) | 12.32 11.91 | |
23/05/2025 | UBS Group AG | 1306(L) | 129,973,185(L) | 471,276,913(L) 456,359,150(S) | 12.53 12.13 | |
20/05/2025 | UBS Group AG | 1306(L) | 12,781,100(L) | 462,166,213(L) 464,387,150(S) | 12.29 12.35 | |
19/05/2025 | UBS Group AG | 1305(L) | 148,944,620(L) | 474,250,103(L) 465,440,150(S) | 12.61 12.37 | |
16/05/2025 | UBS Group AG | 1305(L) | 20,836,628(L) | 463,523,580(L) 465,575,150(S) | 12.32 12.38 | |
15/05/2025 | UBS Group AG | 1306(L) | 158,785,020(L) | 463,494,079(L) 465,703,150(S) | 12.32 12.38 | |
13/05/2025 | UBS Group AG | 1305(L) | 158,123,120(L) | 484,289,585(L) 477,545,881(S) | 12.87 12.70 | |
12/05/2025 | UBS Group AG | 1306(L) | 150,951,776(L) | 473,142,041(L) 473,871,381(S) | 12.58 12.60 | |
07/05/2025 | UBS Group AG | 1305(L) | 157,800,417(L) | 469,676,353(L) 473,027,881(S) | 12.49 12.57 | |
05/05/2025 | UBS Group AG | 1306(L) | 157,192,708(L) | 468,837,056(L) 472,524,381(S) | 12.46 12.56 | |
28/04/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | LuYe Pharmaceutical International Co., Ltd. | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | Luye Pharma Holdings Ltd. | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | Luye Life Sciences Group Ltd | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | Nelumbo Investments Limited | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | Ginkgo (PTC) Limited | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | Shorea LBG | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | 刘殿波 | 1314(L) | +2,000,000(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 | |
22/04/2025 | Luye Life Sciences Group Ltd | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Nelumbo Investments Limited | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Ginkgo (PTC) Limited | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | 刘殿波 | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | LuYe Pharmaceutical International Co., Ltd. | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Nelumbo Investments Limited | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Luye Pharma Holdings Ltd. | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Luye Life Sciences Group Ltd | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Shorea LBG | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | LuYe Pharmaceutical International Co., Ltd. | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Shorea LBG | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Luye Pharma Holdings Ltd. | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | 刘殿波 | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Ginkgo (PTC) Limited | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
21/04/2025 | UBS Group AG | 1305(L) | 13,369,550(L) | 465,328,456(L) 464,873,640(S) | 12.37 12.36 | |
16/04/2025 | UBS Group AG | 1305(L) | 129,682,526(L) | 456,669,828(L) 463,472,105(S) | 12.14 12.32 | |
15/04/2025 | UBS Group AG | 1306(L) | 131,986,981(L) | 456,832,580(L) 463,053,391(S) | 12.14 12.31 | |
1 2 3 4 5 6 |
备注: | (L) - 长仓:包括 (1) 持有股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任购买相关股份。 |
(S) - 短仓:包括 (1) 借入股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任沽出相关股份。 | |
(P) - 可供借出的股份 | |
即时报价更新时间为 06/06/2025 17:59 | |
港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |